Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of glutamate receptor signaling pathway. [GOC:BHF, GOC:TermGenie]
Positive regulation of glutamate receptor signaling pathway involves a complex interplay of molecular mechanisms that enhance the activity of glutamate receptors, which are crucial for synaptic transmission and neuronal plasticity. The process begins with the binding of glutamate, the primary excitatory neurotransmitter in the brain, to its cognate receptor. This binding triggers a cascade of intracellular events, ultimately leading to the activation of downstream signaling pathways. Key mechanisms involved in positive regulation of glutamate receptor signaling include:
1. **Phosphorylation:** Glutamate receptor subunits can be phosphorylated by various kinases, such as calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase A (PKA), and tyrosine kinases. Phosphorylation can enhance receptor function by increasing their affinity for glutamate, promoting their trafficking to the synapse, or altering their interaction with intracellular signaling molecules.
2. **Modulatory proteins:** A diverse range of proteins interact with glutamate receptors, modulating their activity. These include scaffolding proteins, such as PSD-95, which anchor receptors to the postsynaptic density, and accessory proteins, such as TARPs (transmembrane AMPA receptor regulatory proteins), which regulate the trafficking and gating of AMPA receptors.
3. **Synaptic plasticity:** Long-term potentiation (LTP), a form of synaptic plasticity that underlies learning and memory, involves the enhancement of glutamate receptor signaling. LTP can be triggered by high-frequency stimulation, which leads to an increase in postsynaptic calcium levels. This calcium influx activates various signaling pathways, including those involving CaMKII and PKA, which contribute to the phosphorylation and stabilization of glutamate receptors, enhancing synaptic strength.
4. **Neurotrophic factors:** Neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), play a crucial role in regulating glutamate receptor signaling. BDNF promotes the synthesis and trafficking of glutamate receptors, as well as their phosphorylation and stabilization, thereby contributing to synaptic plasticity and neuronal survival.
5. **Glial cells:** Astrocytes, a type of glial cell, contribute to the regulation of glutamate receptor signaling. Astrocytes release gliotransmitters, such as glutamate, which can modulate synaptic transmission. They also play a role in clearing glutamate from the synapse, thereby regulating receptor activation.
6. **Intracellular signaling cascades:** Glutamate receptor activation initiates a complex web of intracellular signaling cascades, including the activation of second messenger systems, such as the cAMP and IP3 pathways. These signaling pathways can further amplify and propagate the initial signal, leading to downstream effects on gene expression, neuronal plasticity, and behavior.
Positive regulation of glutamate receptor signaling is a highly dynamic process, modulated by a diverse array of factors. Its precise regulation is essential for normal brain function, including cognition, memory, and behavior. Dysregulation of this process has been implicated in various neurological disorders, such as epilepsy, Alzheimer's disease, and schizophrenia.
Therefore, understanding the intricate mechanisms underlying positive regulation of glutamate receptor signaling is critical for developing effective therapeutic strategies for these debilitating conditions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Major prion protein | A PRNP gene translation product (human) that is encoded by the major prion protein open reading frame, as opposed to the alternate reading frame. [PRO:DAN] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
quinacrine | quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9. Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
carbamazepine | carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant. Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
chloroquine | chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis. Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug |
chlorpromazine | chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
haloperidol | haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
imipramine | imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom. Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
phenazine | azaarene; heteranthrene; mancude organic heterotricyclic parent; phenazines; polycyclic heteroarene | ||
promazine | promazine : A phenothiazine deriative in which the phenothiazine tricycle has a 3-(dimethylaminopropyl) group at the N-10 position. Promazine: A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
promethazine | promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. | phenothiazines; tertiary amine | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative |
acepromazine | acepromazine : A member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10. Acepromazine: A phenothiazine that is used in the treatment of PSYCHOSES. | aromatic ketone; methyl ketone; phenothiazines; tertiary amino compound | phenothiazine antipsychotic drug |